The new cyclosporine derivative, SDZ IMM 125: in vitro and in vivo pharmacologic effects.
Hiestand
P C
PC
Preclinical Research, Sandoz Pharma, Ltd, Basel, Switzerland.
Gräber
M
M
Hurtenbach
U
U
Herrmann
P
P
Cammisuli
S
S
Richardson
B P
BP
Eberle
M K
MK
Borel
J F
JF
D000818:Animals; D000917:Antibody Formation; D001169:Arthritis, Experimental / Q000276:immunology / Q000517:prevention & control; D002999:Clone Cells; D003524:Cyclosporins / Q000494:pharmacology*; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology / Q000517:prevention & control; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology; D006087:Graft vs Host Reaction / Q000187:drug effects; D016027:Heart Transplantation / Q000276:immunology; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007108:Immune Tolerance; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D051379:Mice; D008807:Mice, Inbred BALB C; D051381:Rats; D011917:Rats, Inbred Lew; D012710:Serum Albumin, Bovine / Q000276:immunology; D012756:Sheep / Q000097:blood; D006377:T-Lymphocytes, Helper-Inducer / Q000166:cytology / Q000276:immunology; D016042:Transplantation, Heterotopic / Q000276:immunology; D014184:Transplantation, Homologous; D014605:Uveitis / Q000517:prevention & control
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D012710:Serum Albumin, Bovine; C075935:SDZ IMM 125